已收盤 09-26 16:00:00 美东时间
-0.300
-1.30%
中国医疗大模型,登上国际顶刊新闻版面! 近日,Nature的新闻版面刊登了一则关于中国医疗大模型的报道,引发行业广泛关注。作为世界上创刊最早、影响力最高的国际性...
09-25 08:04
Survey reveals talent, trust, and connection — not badge swipes — fuel success among remote-first companies CAMBRIDGE, Mass., Sept. 24, 2025 /PRNewswire/ -- Think productivity requires a ret...
09-24 21:02
Omada Health's analysis shows that 63% of members maintained or continued to lose weight 12 months after discontinuing GLP-1s, with an average weight change of just 0.8%. This contrasts with typical 11-12% weight gain seen in clinical trials, highlighting the impact of continued lifestyle support. The study emphasizes the importance of sustained support for weight maintenance post-GLP-1 treatment, offering insights for employers managing rising G...
09-08 13:00
Baird analyst Vikram Kesavabhotla initiates coverage on Omada Health (NASDAQ:OMDA) with a Neutral rating and announces Price Target of $24.
09-05 19:13
Omada Health released a study showing that virtual physical therapy (V-PT) for musculoskeletal conditions resulted in lower healthcare costs and utilization compared to in-person PT, even when factoring in program costs. The research, using claims data from 2019 to 2023, found $100+ monthly savings per member and a positive ROI of 1.8x within six months. Virtual PT overcomes barriers like geographic access and high costs, offering a cost-effectiv...
08-28 13:00
Omada Health announced that senior management will participate in Morgan Stanley's 23rd Annual Global Healthcare Conference in New York on September 9, 2025. They will hold a fireside chat at 5:35 pm ET, with a live webcast and replay available at investors.omadahealth.com. As a virtual-first healthcare provider, Omada helps improve health outcomes for those with chronic conditions like diabetes and hypertension, with over a decade of experience ...
08-26 13:00
核心要点 本周 Bullish 的 IPO 是华尔街再次对新科技公司上市表现出热情的最新迹象。 在 Bullish 股价上涨 84% 之前,Fig...
08-16 23:35
今日重点评级关注:RBC Capital:维持Edgewise Therapeutics"跑赢大市"评级,目标价从48美元升至49美元;RBC Capital:维持Nuvation Bio"跑赢大市"评级,目标价从6美元升至7美元
08-11 09:43
Needham analyst Ryan MacDonald maintains Omada Health (NASDAQ:OMDA) with a Buy and raises the price target from $23 to $24.
08-08 17:57
Omada Health (NASDAQ:OMDA) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.14) by 71.43 percent. This is a 82.86 percent increase over losses of $(1.40) per share from
08-08 04:09